#Oncology

Articles (17)

• 🇺🇸 Gilead exercises option on Kymera’s CDK2 degrader for $45M — 09/04/2026 [USA] Related: #Biopharma, #Business Deal
• 🇺🇸 MO-RiskVAE: A Multi-Omics Variational Autoencoder for Survival Risk Modeling in Multiple MyelomaMO-RiskVAE — 09/04/2026 [USA]

  arXiv:2604.06267v1 Announce Type: cross Abstract: Multimodal variational autoencoders (VAEs) have emerged as a powerful framework for survival risk modeling in multiple myeloma by integrating heterog...

  Related: #Artificial Intelligence, #Medical Research
• 🇺🇸 MorphDistill: Distilling Unified Morphological Knowledge from Pathology Foundation Models for Colorectal Cancer Survival Prediction — 09/04/2026 [USA]

  arXiv:2604.06390v1 Announce Type: cross Abstract: Background: Colorectal cancer (CRC) remains a leading cause of cancer-related mortality worldwide. Accurate survival prediction is essential for trea...

  Related: #Medical AI, #Technology
• 🇺🇸 Stress Estimation in Elderly Oncology Patients Using Visual Wearable Representations and Multi-Instance Learning — 09/04/2026 [USA]

  arXiv:2604.06990v1 Announce Type: cross Abstract: Psychological stress is clinically relevant in cardio-oncology, yet it is typically assessed only through patient-reported outcome measures (PROMs) a...

  Related: #Digital Health, #Artificial Intelligence
• 🇺🇸 GSK receives orphan drug status in Japan for lung cancer therapy risvutatug rezetecan — 23/03/2026 [USA] Related: #Pharmaceutical Regulation
• 🇺🇸 HUTCHMED begins phase III trial of HMPL-760 for lymphoma in China — 23/03/2026 [USA] Related: #Clinical Trials
• 🇺🇸 Genprex collaborators to present lung cancer data at AACR meeting — 18/03/2026 [USA] Related: #Medical Research
• 🇺🇸 Zymeworks to present clinical data on cancer drug candidate at AACR — 17/03/2026 [USA] Related: #Clinical Research
• 🇺🇸 Immutep to discontinue TACTI-004 Phase III study in first line NSCLC — 16/03/2026 [USA] Related: #Clinical Trial
• 🇺🇸 AstraZeneca wins EU approval for Imfinzi in early gastric cancer — 16/03/2026 [USA] Related: #Pharmaceutical Approval
• 🇺🇸 Celcuity at Leerink Conference: Promising Breast Cancer Drug Results — 10/03/2026 [USA] Related: #Clinical Trials
• 🇺🇸 Deep Learning-Based Approach for Automatic 2D and 3D MRI Segmentation of Gliomas — 10/03/2026 [USA]

  arXiv:2502.19760v1 Announce Type: cross Abstract: Brain tumor diagnosis is a challenging task for clinicians in the modern world. Among the major reasons for cancer-related death is the brain tumor. ...

  Related: #Medical Imaging, #AI in Healthcare
• 🇺🇸 Calidi Biotherapeutics closes $6M public offering — 10/03/2026 [USA] Related: #Biotechnology, #Finance
• 🇺🇸 Telix prostate cancer drug trial meets safety goals — 09/03/2026 [USA] Related: #Clinical Trials
• 🇺🇸 Roche breast cancer drug combo misses main goal in late-stage trial — 09/03/2026 [USA] Related: #Clinical Trial
• 🇺🇸 FDA issues complete response letter for Incyte’s Zynyz application in lung cancer — 06/03/2026 [USA] Related: #Regulatory
• 🇺🇸 BBOT publishes preclinical data on panKRAS inhibitor BBO-11818 — 06/03/2026 [USA] Related: #Drug Development